ДИФФЕРЕНЦИРОВАННЫЙ ВЫБОР МЕТОДА И СРОКОВ РЕВАСКУЛЯРИЗАЦИИ ПРИ ГЕМОДИНАМИЧЕСКИ ЗНАЧИМЫХ СТЕНОЗАХ СОННЫХ АРТЕРИЙ В УСЛОВИЯХ ЦЕНТРА ЭКСТРЕННОЙ МЕДИЦИНСКОЙ ПОМОЩИ

Authors

  • Фарход Абдиганиевич Маматалиев Республиканский научный центр экстренной медицинской помощи Ташкент, Узбекистан https://orcid.org/0000-0002-3279-1092
  • Абдусалом Абдурахманов доктор медицинских наук, Республиканский научный центр экстренной медицинской помощи, Ташкент, Узбекистан https://orcid.org/0000-0001-7785-1036

DOI:

https://doi.org/10.5281/zenodo.23942659

Keywords:

hemodynamically significant carotid artery stenosis, crescendo TIA, carotid artery stenting, carotid endarterectomy, timing of revascularization, emergency medicine

Abstract

Objective. To substantiate the differentiated selection of the method and timing of carotid revascularization in patients with symptomatic, hemodynamically significant carotid artery stenosis treated at a multidisciplinary emergency medical center. Materials and Methods. The treatment outcomes of 110 patients who underwent surgery at the Republican Research Centre of Emergency Medicine (RRCEM) between 2021 and 2025 were analyzed. Carotid endarterectomy (CEA) was performed in 60 patients (54.5%), while carotid angioplasty with stenting (CAS) was performed in 50 patients (45.5%). All patients were symptomatic and underwent surgery within 14 days of the index cerebrovascular event. The revascularization method and timing were determined by a multidisciplinary team based on clinical, anatomical, and morphological criteria, using duplex ultrasonography (DUS) and multislice computed tomography angiography (MSCTA). Results. Ultra-early stenting, performed within the first 48 hours, was carried out in 10 patients (20.0%) in the CAS group who presented with progressive or recurrent transient ischemic attacks (crescendo TIA) and internal carotid artery (ICA) stenosis ≥ 70%. None of these patients experienced progression to a completed ischemic stroke. Open surgical interventions were predominantly performed on days 8–14 (80.0% of the group). The cumulative incidence of major adverse cardiovascular events within 30 days was 2.0% after CAS and 3.3% after CEA (p = 1.00), while the overall mortality rate was 1.8%. The National Institutes of Health Stroke Scale (NIHSS) score decreased by 2.8 ± 0.9 and 2.7 ± 0.8 points, respectively (p < 0.001 in both groups). The pattern of complications differed between the groups: complications related to surgical access were more frequent after CEA (5.0% vs. 2.0%), whereas systemic non-cerebral complications were more common after CAS (10.0% vs. 1.7%). Conclusion. A differentiated approach to selecting the method and timing of carotid revascularization, implemented within the Stroke Team model, is associated with low perioperative mortality and enables patients with unstable cerebrovascular symptoms to undergo surgical intervention safely within an ultra-early timeframe.

References

1. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. (1991). New England Journal of Medicine, 325(7), 445–453. https://doi.org/10.1056/NEJM199108153250701

2. European Carotid Surgery Trialists’ Collaborative Group. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: Final results of the MRC European Carotid Surgery Trial (ECST). (1998). The Lancet, 351(9113), 1379–1387. https://doi.org/10.1016/S0140-6736(97)09292-1

3. Rothwell, P. M., Eliasziw, M., Gutnikov, S. A., et al. (2003). Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. The Lancet, 361(9352), 107–116. https://doi.org/10.1016/S0140-6736(03)12228-3

4. Rothwell, P. M., Eliasziw, M., Gutnikov, S. A., et al. (2004). Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. The Lancet, 363(9413), 915–924. https://doi.org/10.1016/S0140-6736(04)15785-1

5. Brott, T. G., Hobson, R. W., Howard, G., et al. (2010). Stenting versus endarterectomy for treatment of carotid-artery stenosis. New England Journal of Medicine, 363(1), 11–23. https://doi.org/10.1056/

6. Ederle, J., Dobson, J., Featherstone, R. L., et al. (2010). Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): An interim analysis of a randomised controlled trial. The Lancet, 375(9719), 985–997. https://doi.org/10.1016/

7. SPACE Collaborative Group; Ringleb P. A., Allenberg J., Brückmann H., et al. 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: A randomised non-inferiority trial. (2006). The Lancet, 368(9543), 1239–1247. https://doi.org/10.1016/S0140-6736(06)69122-8

8. Voeks, J. H., Howard, G., Roubin, G. S., et al. (2011). Age and outcomes after carotid stenting and endarterectomy: The Carotid Revascularization Endarterectomy versus Stenting Trial. Stroke, 42(12), 3484–3490. https://doi.org/10.1161/STROKEAHA.111.624155

9. Carotid Stenting Trialists’ Collaboration; Bonati L. H., Dobson J., Algra A., et al. Short-term outcome after stenting versus endarterectomy for symptomatic carotid stenosis: A preplanned meta-analysis of individual patient data. (2010). The Lancet, 376(9746), 1062–1073. https://doi.org/10.1016/S0140-6736(10)61009-4

10. Naylor, A. R., Rantner, B., Ancetti, S., et al. (2023). Editor’s Choice — European Society for Vascular Surgery (ESVS) 2023 Clinical Practice Guidelines on the Management of Atherosclerotic Carotid and Vertebral Artery Disease. European Journal of Vascular and Endovascular Surgery, 65(1), 7–111. https://doi.org/10.1016/j.ejvs.2022.04.011

11. Brott, T. G., Howard, G., Roubin, G. S., et al. (2016). Long-term results of stenting versus endarterectomy for carotidartery stenosis. New England Journal of Medicine, 374(11), 1021–1031. https://doi.org/10.1056/NEJMoa1505215

12. Fox, A. J. (1993). How to measure carotid stenosis. Radiology, 186(2), 316–318. https://doi.org/10.1148/radiology.186.2.8421726

13. World Medical Association. World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. (2013). JAMA, 310(20), 2191–2194. https://doi.org/10.1001/

14. Brott, T., Adams, H. P. Jr., Olinger, C. P., et al. (1989). Measurements of acute cerebral infarction: A clinical examination scale. Stroke, 20(7), 864–870. https://doi.org/10.1161/01.STR.20.7.864

15. van Swieten, J. C., Koudstaal, P. J., Visser, M. C., Schouten, H. J. A., & van Gijn, J. (1988). Interobserver agreement for the assessment of handicap in stroke patients. Stroke, 19(5), 604–607. https://doi.org/10.1161/01.STR.19.5.604

16. Gray-Weale, A. C., Graham, J. C., Burnett, J. R., Byrne, K., & Lusby, R. J. (1988). Carotid artery atheroma: Comparison of preoperative B-mode ultrasound appearance with carotid endarterectomy specimen pathology. Journal of Cardiovascular Surgery, 29(6), 676–681.

17. GBD 2021 Stroke Risk Factor Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990–2021: A systematic analysis for the Global Burden of Disease Study 2021. (2024). The Lancet Neurology, 23(10), 973–1003. https://doi.org/10.1016/S1474-4422(24)00369-7

18. Kleindorfer, D. O., Towfighi, A., Chaturvedi, S., et al. (2021). 2021 Guideline for the prevention of stroke in patients with stroke and transient ischemic attack: A guideline from the American Heart Association/American Stroke Association. Stroke, 52(7). https://doi.org/10.1161/STR.0000000000000375

19. Fereydooni, A., Gorecka, J., Xu, J., Schindler, J., & Dardik, A. (2019). Carotid endarterectomy and carotid artery stenting for patients with crescendo transient ischemic attacks: A systematic review. JAMA Surgery, 154(11), 1055–1063. https://doi.org/10.1001/jamasurg.2019.2952

20. Ois, A., Cuadrado-Godia, E., Rodríguez-Campello, A., Jiménez-Conde, J., & Roquer, J. (2009). High risk of early neurological recurrence in symptomatic carotid stenosis. Stroke, 40(8), 2727–2731. https://doi.org/10.1161/STROKEAHA.109.548032

21. Yadav, J. S., Wholey, M. H., Kuntz, R. E., et al. (2004). Protected carotid-artery stenting versus endarterectomy in high-risk patients. New England Journal of Medicine, 351(15), 1493–1501. https://doi.org/10.1056/NEJMoa040127

22. AbuRahma, A. F., Avgerinos, E. D., Chang, R. W., et al. (2022). Society for Vascular Surgery clinical practice guidelines for management of extracranial cerebrovascular disease. Journal of Vascular Surgery, 75(1). https://doi.org/10.1016/j.jvs.2021.04.073

23. Theiss, W., Hermanek, P., Mathias, K., et al. (2004). Pro-CAS: A prospective registry of carotid angioplasty and stenting. Stroke, 35(9), 2134–2139. https://doi.org/10.1161/01.STR.0000135763.62131.6a

24. Müller, M. D., Lyrer, P., Brown, M. M., & Bonati, L. H. (2020). Carotid artery stenting versus endarterectomy for treatment of carotid artery stenosis. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.CD000515.pub5

25. Bonati, L. H., Kakkos, S., Berkefeld, J., et al. (2021). European Stroke Organisation guideline on endarterectomy and stenting for carotid artery stenosis. European Stroke Journal, 6(2). https://doi.org/10.1177/23969873211012121

Downloads

Published

2026-10-31

How to Cite

1.
Маматалиев ФА, Абдурахманов А. ДИФФЕРЕНЦИРОВАННЫЙ ВЫБОР МЕТОДА И СРОКОВ РЕВАСКУЛЯРИЗАЦИИ ПРИ ГЕМОДИНАМИЧЕСКИ ЗНАЧИМЫХ СТЕНОЗАХ СОННЫХ АРТЕРИЙ В УСЛОВИЯХ ЦЕНТРА ЭКСТРЕННОЙ МЕДИЦИНСКОЙ ПОМОЩИ. TTI [Internet]. 2026 Oct. 31 [cited 2026 Nov. 18];2(10):700-11. Available from: https://tibbiyot-talimi-va-innovatsiyalari.uz/index.php/TTI/article/view/228
Vol. 2 No. 10 (2026): Journal of "Medical Education and Innovations"